Your browser doesn't support javascript.
loading
Docetaxel treatment for widely metastatic invasive vulvar extramammary Paget's disease with multifocal bone metastasis.
Aroche Gutierrez, Larissa L; Holloway, Steven B; Donthi, Deepak; Lea, Jayanthi S.
Afiliação
  • Aroche Gutierrez LL; Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
  • Holloway SB; Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
  • Donthi D; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
  • Lea JS; Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
Gynecol Oncol Rep ; 45: 101114, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36578967
•Invasive extramammary Paget's disease of the vulva is rare.•Distant metastasis has a very poor prognosis.•Given rarity of disease, no standardized treatment exists.•Single agent docetaxel is a viable treatment for metastatic invasive extramammary Paget's disease.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article